Literature DB >> 6102030

Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey.

W R McConnell, S M El Dareer, D L Hill.   

Abstract

erythro-9-(2-Hydroxy-3-nonyl)[14C]adenine was extensively metabolized by monkeys. Following iv administration of 5 mg/kg, serum levels of total radioactivity increased to a maximum between 15 and 30 min, then dropped rapidly. Thin-layer chromatography of extracts of liver, kidney, and urine revealed four metabolites. Of the radioactivity administered, urinary excretion accounted for 70% within 6 hr and 90% within 1 week. In serum, the concentration of intact drug declined rapidly; in urine, it constituted less than 0.3% of the total radioactivity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102030

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  2 in total

Review 1.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening.

Authors:  Rebecca N Adamek; Paul Ludford; Stephanie M Duggan; Yitzhak Tor; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-10-14       Impact factor: 3.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.